Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder

International Journal of Geriatric Psychiatry

Volumn 22, Issue 11, 2007, Pages 1141-1146

  Saghafi, Ramin ^a,b,c   Brown, Charlotte ^a,b,c   Butters, Meryl A ^a,b,c   Cyranowski, Jill ^a,b,c   Dew, Mary Amanda ^a,b,c   Frank, Ellen ^a,b,c   Gildengers, Ariel ^a,b,c   Karp, Jordan F ^a,b,c   Lenze, Eric J ^a,b,c   Lotrich, Francis ^a,b,c   Martire, Lynn ^a,b,c   Mazumdar, Sati ^a,b,c   Miller, Mark D ^a,b,c   Mulsant, Benoit H ^a,d   Weber, Elizabeth ^a,b,c   Whyte, Ellen ^a,b,c   Morse, Jennifer ^a,b,c   Stack, Jacqueline ^a,b,c   Houck, Patricia R ^a,b,c   Bensasi, Salem ^a,b,c   Reynolds III, Charles F ^a,b,c,e   more..

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e NONE   (United States)

Author keywords

Escitalopram; Major depression; Old age; Treatment response

Indexed keywords

BENZODIAZEPINE; ESCITALOPRAM; PSYCHOTROPIC AGENT;

ADULT; AGED; ANXIETY; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG RESPONSE; FEMALE; GERIATRIC CARE; HAMILTON SCALE; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; QUALITY OF LIFE; SELF ESTEEM; SOCIAL SUPPORT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SELF CONCEPT; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 36249009011     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1804     Document Type: Article

References (33)

1. Alexopoulos GS, Katz IR, Bruce ML, et al. and the PROSPECT Group. 2005. Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry 162: 718-724.
2. Alexopoulos GS, Meyers BS, Young RC, et al. 2000. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 57: 285-290.
3. Andreescu C, Lenze EJ, Dew MA, et al. in press. Impact of anxiety on response and recurrence of major depressive disorder in old age: a randomized, double-blind, placebo-controlled maintenance study. British Journal of Psychiatry.
4. Beck AT, Weissman A, Lester D, Trexler L. 1974. The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol 42: 861-865.
5. Bruce ML, Ten Have TR, Reynolds CF, et al. 2004. Reducing suicidal ideation and depressive symptoms in depressed older pnmary care patients: a randomized controlled trial. JAMA 291: 1081-1091.
6. Bush JW, Anderson JP, Kaplan RM, Blischke WR. 1982. 'Counter-intuitive' preferences in health-related quality-of-life measurement. Med Care 20: 516-525.
7. Cohen A, Houck PR, Szanto K, et al. 2006. Social inequalities in response to antidepressant treatment in older adults. Arch Gen Psychiatry 63: 50-56.
8. Cohen S, Mermelstein R, Kamarck T, Hoberman HM. 1985. Measuring the functional components of social support. In Social Support: Theory, Researrh and Applications, Sarason IG, Sarason B. (eds). Martinus Nijhoff. The Hague; 73-94.
9. Cooper LA, Gonzales JJ, Gallo JJ, et al. 2003. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care 41: 479-489.
10. Cuffel BJ, Azocar F, Tomlin M, et al. 2003. Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice. J Clin Psychiatry 64: 397-402.
11. Dew MA, Reynolds CF, Houck PR, et al. 1997. Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 54: 1016-1024.
12. Dew MA, Reynolds CF, Mulsant B, et al. 2001. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. J Affect Disord 65: 155-166.
13. Fava GA, Grandi S, Zielezny M, et al. 1996. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Randomized control trial. Am J Psychiatry 153: 945-947.
14. Flint AJ, Rifat SL. 1997. Anxious depression in elderly patients. Response to antidepressant treatment. Am J Geriatr Psychiatry 5: 107-115.
15. Folstein MF, Folstein SW, McHugh PR. 1975. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
16. Gildengers AG, Houck PR, Mulsant BH, et al. 2005. Trajectories of treatment response in late-life depression: psychosocial and clinical correlates. J Clin Psychcopharmacol 25: S8-S13.
17. Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55.
18. Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278-296.
19. Karp JF, Buysse DJ, Houck PP, et al. 2004. Relationship of variability in residual symptoms with recurrence of major depressive disorder during mainentance treatment. Am J Psychiatry 161: 1877-1884.
20. Lenze EJ, Mulsant BH, Shear MK, et al. 2002. Anxiety symptoms in elderly patients with depression: what is the best approach to treatment? Drugs Aging 19: 753-760.
21. Little JT, Reynolds CF, Dew MA, et al. 1998. How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? Am J Psychiatry 155: 1035-1038.
22. Lotrich F, Pollock BG, Ferrell RE. 2001. Polymorphism of the serotonin transporter: implications for the use of specific serotonin reuptake inhibitors. Am J Pharmacogenomics 1: 153-164.
23. Lotrich FE, Pollock BG, Ferrell RE. 2003. Serotonin transporter promoter polymorphism in African Americans: allele frequencies and implications for treatment of depression. Am J Pharmacogenomics 3: 145-147.
24. Mattis S. 1988. Dementia Rating Scale (DRS) Psychological Assessment Resources: Odessa, FL.
25. Miller MD, Paradis CF, Houck PR, et al. 1992. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41: 237-248.
26. Mulsant BH, Houck PR, Gildengers AG, et al. 2006. What is the optimal duration of a short-term antidepressant trial when treating geriatric depression? J Clin Psychopharmacol 26: 113-120.
27. Mulsant BH, Reynolds CF, Shear MK, et al. 1996. Comorbid anxiety disorders in late-life depression. Anxiety 2: 242-247.
28. Sackeim HA, Haskett RF, Mulsant BH, et al. 2001. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. JAMA 285: 1299-1307.
29. Steffens DC, McQuoid DR. 2005. Impact of symptoms of generalized anxiety disorder on the course of late-life depression. Am J Geriatr Psychiatry 13: 40-47.
30. Stokes ME, Davis CS, Koch GG. 1995. Categorical Data Analysis Using the SAS Sytem. SAS Institute Inc.: Carey, N.C.
31. Thomas L, Mulsant BH, Solano FX, et al. 2002. Response speed and rate of remission in primary and specialty care of elderly patients with depression. Am J Geriatr Psychiatry 10: 583-591.
32. Ware JE, Sherbourne CD. 1992. The MOS-36-Item short form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30: 473-483.
33. Whyte EM, Dew MA, Gildengers A, et al. 2004. Time course of response to antidepressants in late-life nrajor depression: therapeutic implications. Drugs Aging 21: 531-554.